Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data

Author:

Pourzinal Dana1,Lawson Rachael A.2,Yarnall Alison J.2,Williams‐Gray Caroline H.3,Barker Roger A.3,Yang Jihyun1,McMahon Katie L.4,O'Sullivan John D.15,Byrne Gerard J.16,Dissanayaka Nadeeka N.15ORCID

Affiliation:

1. Faculty of Medicine The University of Queensland Centre for Clinical Research Herston Queensland Australia

2. Translational and Clinical Research Institute Newcastle University Newcastle Newcastle Upon Tyne UK

3. Department of Clinical Neuroscience John van Geest Centre for Brain Repair University of Cambridge Cambridgeshire UK

4. School of Clinical Sciences Faculty of Health Queensland University of Technology Brisbane Queensland Australia

5. Department of Neurology Royal Brisbane & Women's Hospital Herston Queensland Australia

6. Mental Health Service Royal Brisbane & Women's Hospital Herston Queensland Australia

Abstract

AbstractIntroductionA subset of people with Parkinson's disease (PD) develop dementia faster than others. We aimed to profile PD cognitive subtypes at risk of dementia based on their rate of cognitive decline.MethodLatent class mixed models stratified subtypes in Parkinson's Progression Markers Initiative (PPMI) (= 770) and ICICLE‐PD (= 212) datasets based on their decline in the Montreal Cognitive Assessment over at least 4 years. Baseline demographic and cognitive data at diagnosis were compared between subtypes to determine their clinical profile.ResultsFour subtypes were identified: two with stable cognition, one with steady decline, and one with rapid decline. Performance on Judgement of Line Orientation, but not category fluency, was associated with a steady decline in the PPMI dataset, and deficits in category fluency, but not visuospatial function, were associated with a steady decline in the ICICLE‐PD dataset.DiscussionPeople with PD susceptible to cognitive decline demonstrate unique clinical profiles at diagnosis, although this differed between cohorts.Highlights Four cognitive subtypes were revealed in two Parkinson's disease samples. Unique profiles of cognitive impairment were related to cognitive decline. Judgement of Line Orientation/category fluency predictive of steady decline. Global deficits related to rapid cognitive decline and increased dementia risk.

Funder

National Institute for Health and Care Research

NIHR Newcastle Biomedical Research Centre

Parkinson's UK

NIHR Cambridge Biomedical Research Centre

AbbVie

Allergan

Amathus Therapeutics

Aligning Science Across Parkinson's

Avid Radiopharmaceuticals

Biogen

Bristol-Myers Squibb

Celgene

Cerevel Therapeutics

Genentech

GlaxoSmithKline

H. Lundbeck A/S

Merck

Neurocrine Biosciences

Pfizer

Roche

Sanofi

Servier

UCB

Voyager Therapeutics

Weston Family Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3